Osool & Bakheet issues Q2 2024 earnings forecastArgaam09/07/2024
Jamjoom Pharma provides corporate guarantee to Algeria JVArgaam08/07/2024
GIB Capital previews Q2 2024 earningsArgaam07/07/2024
Osool & Bakheet issues Q2 2024 earnings forecastArgaam09/07/2024
GIB Capital previews Q2 2024 earningsArgaam07/07/2024
United Securities sets rating, TP for Jamjoom PharmaArgaam19/05/2024
Key events likely to impact Saudi-listed firms’ earnings in Q2 2024Argaam Special04/07/2024
Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023Argaam Special21/04/2024
Highest-paid executives, board members of Saudi-listed firms in 2023Argaam Special16/04/2024
Jamjoom Pharma seen to post profit growth in Q4 2023Argaam Special20/02/2024
How did analysts view TASI performance, top picks for 2024?Argaam Special09/01/2024
Market Data
Last Trade | 143.00 |
Change | (1.20) |
Change (%) | (0.83) |
Open | 144.00 |
Low | 143.00 |
High | 145.20 |
Prev. Close | 144.20 |
Change (3M) | 8.33 % |
Change (6M) | 18.77 % |
Volume | 65,513 |
Turnover | 9,413,693.00 |
Transactions | 1,157 |
Market Value | 10,010.00 |
Avg. Volume (3M) | 182,142.84 |
Avg. Turnover (3M) | 24,963,820.17 |
Avg. Transaction (3M) | 1,812.55 |
Change(12M) | 26.10 % |
YTD | 24.35 % |
Event Date
|
Event
|
Venue
|
|
---|---|---|---|
04-07-2024
|
General Assembly | - | |
13-06-2024
|
Cash Dividend Distribution | - | |
04-06-2024
|
General Assembly | - | |
04-06-2024
|
Ex-dividend Date | - | |
25-03-2024
|
Conferences | - | |
more |
Date | Research firm | Rating |
|
United Securities Company | Buy |
|
United Securities Company | Hold |
|
GIB Capital | Neutral |
|
Al Rajhi Capital | Overweight |
Call Request